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region including the  DYRK1A gene and excluding  RUNX1 . 
These patients present with a recognizable phenotype
specific for this 21q22.1–q22.2 locus. We searched the litera-
ture for patients with overlapping deletions including the 
 DYRK1A gene, in order to define other genes responsible for 
this presentation.  Copyright © 2010 S. Karger AG, Basel 
 Chromosome 21 has been the subject of extensive 
studies. Trisomy 21 causing Down syndrome [DS, OMIM 
#190685] is one of the few trisomy syndromes compatible 
with life and is common with an incidence of about 1 in 
800 live births. However, (partial) monosomy 21 is much 
rarer and few patients have been reported in literature 
[Holbek et al., 1974; Fryns et al., 1977; Matsui et al., 1978; 
Yamamoto et al., 1979; Pellissier et al., 1987; Korenberg et 
al., 1991; Krasikov et al., 1992; Chettouh et al., 1995; Huret 
et al., 1995; Theodoropoulos et al., 1995; Bartsch et al., 
1997; Joosten et al., 1997; Matsumoto et al., 1997; Ehling 
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 Abstract 
 Partial monosomy 21 has been reported, but the pheno-
types described are variable with location and size of the 
deletion. We present 2 patients with a partially overlapping 
microdeletion of 21q22 and a striking phenotypic resem-
blance. They both presented with severe psychomotor de-
lay, behavioral problems, no speech, microcephaly, feeding 
problems with frequent regurgitation, idiopathic thrombo-
cytopenia, obesity, deep set eyes, down turned corners of 
the mouth, dysplastic ears, and small chin. Brain MRI showed 
cerebral atrophy mostly evident in frontal and temporal 
lobes, widened ventricles and thin corpus callosum in both 
cases, and in one patient evidence of a migration disorder. 
The first patient also presented with epilepsy and a ventricu-
lar septum defect. The second patient had a unilateral Peters 
anomaly. Microarray analysis showed a partially overlapping 
microdeletion spanning about 2.5 Mb in the 21q22.1–q22.2 
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et al., 2004; Mori et al., 2004; Yao et al., 2006; Tuschl et 
al., 2007; Beri-Dexheimer et al., 2008; Dobyns et al., 2008; 
Lyle et al., 2009; Miller et al., 2009; Fujita et al., 2010; 
Lindstrand et al., 2010]. The region of the monosomy and 
the phenotype of reported cases are variable. The 21q22 
region seems associated with the most severe phenotype 
exhibiting mental retardation and microcephaly [Yama-
moto et al., 1979]. Disruption of  DYRK1A ( Drosophila 
minibrain homologue gene, OMIM  * 600855) in this re-
gion has been associated with microcephaly, mental re-
tardation and dysmorphisms in 2 patients [Møller et al., 
2008]. Studying similar patients potentially reveals valu-
able information regarding the function of the chromo-
some 21 genes.
 We present 2 unrelated individuals with a partial 
monosomy 21 with strikingly similar facial features giv-
ing them a ‘moody’ appearance, similar brain imaging 
and a partially overlapping 21q22 microdeletion. This 
overlapping 2.5-Mb region contains amongst others the 
 DYRK1A gene and covers the DS critical region [OMIM 
#190685]. Combining our data with previously published 
reports by others, we delineate a recognizable phenotype 
of chromosome 21q22.1–q22.2 microdeletion including 
the  DYRK1A gene.
 Clinical Reports 
 Patient 1 
 Patient 1 was referred to our department at 18 months of age. 
Clinical data are summarized in  table 1 . He was born after an un-
eventful pregnancy at 38 weeks of gestation as the 10th child to 
non-consanguineous healthy Dutch parents. His birth weight was 
2,140 g (–2 SD) and head circumference 31 cm (–2.8 SD). The neo-
natal period was complicated by cardiac decompensation due to 
a persistent ductus arteriosus and a perimembranous ventricular 
septum defect (VSD). The duct closed spontaneously at cardio-
logic follow-up, the VSD was managed conservatively.
 Clinical genetic examination at the age of 18 months showed 
micro- and brachycephaly, square forehead, deep-set eyes with 
long eyelashes, small nose, large pupils, thin lips with down-
turned corners of the mouth, micrognathia, large, low-set ears, 
and weight and head circumference at –4 SD ( fig. 1 ).
 His developmental milestones were delayed. Severe feeding 
problems and gastro-esophageal reflux necessitated gastric tube 
feeding and Nissen fundoplication. He suffered from recurrent 
upper respiratory tract infections and had severe constipation. He 
developed epilepsy with tonic-clonic seizures requiring antiepi-
leptic drug (AED) therapy.
 At follow-up at the age of 7 years he was severely mentally re-
tarded and exhibited no speech. He had a flat forehead, broad 
eyebrows extending onto the eyelids, deep-set eyes with long eye-
lashes, large pupils, wide nasal ridge, large, low-set ears, full 
cheeks, dental caries, micrognathia, small hands and feet, a san-
dal gap between 1st and 2nd toes, joint hyperlaxity, pectus exca-
vatum, truncal obesity, and cryptorchidism ( fig. 1 ). His height was 
110 cm (–3 SD), weight 20 kg (+1 SD), and head circumference 45.5 
cm (–4 SD).
 Abdominal ultrasound and skeletal X-rays revealed no abnor-
malities. A post-operative (tonsillectomy) hemorrhage prompted 
studies of bleeding diathesis, this revealed low platelet counts 
ranging from 82–149  ! 10 9 /l (normal range: 199–369  ! 10 9 /l).
 Brain MRI performed at 1 year of age (fig. 3A, B) showed small 
frontal lobes, enlarged lateral and third ventricles with high signal 
of periventricular white matter on T2 weighted images, a thin 
corpus callosum and brain stem, and delayed myelination. At two 
years of age, brain MRI showed similar features, although my-
elination had progressed.
 He died at age 11 of a bronchopneumonia complicated by pul-
monary hemorrhage.
 Patient 2 
 Patient 2 was referred to our department of Clinical Genetics 
at the age of 8 months because of progressive microcephaly and 
dysmorphic features. She was born after an uneventful pregnancy 
at 42 weeks of gestation as the first child of non-consanguineous 
healthy Chinese parents. Her birth weight was 2,765 g (–2 SD), 
length 46 cm (–3 SD) and head circumference 31 cm (–3.5 SD). She 
had a systolic murmur due to a persistent ductus arteriosus. It 
closed spontaneously on follow-up. In infancy she suffered from 
episodic attacks of blue discoloration of the extremities. She has 
had two seizures suggestive of epilepsy and one EEG showed du-
bious epileptic activity, requiring AED therapy.
 On clinical examination dysmorphic features included square 
forehead with nevus flammeus, low-set and thick eyebrows, long 
eyelashes, peri-orbital fullness with deep set eyes, wide nasal 
ridge, anteverted nares, down-turned corners of the mouth, small 
chin, round ears with broad helices and a left-sided ear pit, in-
verted nipples, a closed sacral dimple, a congenital nevus on the 
back, a single palmar crease on the left hand, a contracture of the 
left thumb, deep set nails of the toes, and bilateral short proxi-
mally implanted first toes ( fig. 2 ).
 Her developmental milestones were delayed. She started walk-
ing independently at age 2. She suffered from feeding problems 
which required gastric tube feeding in infancy. During follow-up 
up to 7 years of age she exhibited severe mental retardation with 
absent speech, no eye contact, hyperactive behavior and poor in-
teraction with people. Teeth grinding was noted and diffuse den-
tal decay was striking. At that age, her height was 110 cm (–3 SD), 
weight 25 kg (2.5 SD), and head circumference 48 cm (–2 SD) . She 
had severe constipation.
 Ophthalmic examination revealed bilateral hypermetropia, 
amblyopia of the right eye, and a unilateral corneal opacity area 
consistent with a Peters anomaly. Her platelet counts were below 
normal range on 2 separate occasions, 104 and 137  ! 10 9 /l (nor-
mal range: 199–369  ! 10 9 /l). Craniosynostosis was excluded with 
a skull X-ray. Congenital CMV-infection was excluded by PCR of 
neonatal screening blood spot. No skeletal abnormalities were de-
tected.
 Brain MRI performed at the age of 5 months and repeated 
MRI at the age of 15 months ( fig. 3 C, D) showed cerebral atrophy 
with deep sulci, mostly evident in frontal and temporal lobes, un-
derdeveloped frontal gyri, a thin corpus callosum with loss of 
periventricular white matter and widened lateral and third ven-
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tricles both at frontal and occipito-temporal areas, a thin brain 
stem, and no evidence for active demyelination.
 Recent brain MRI at the age of 8 years showed evidence of a 
periventricular nodular heterotopia located in the frontal horn of 
the right lateral ventricle. The inferior part of the right frontal 
cortex is abnormal and suggestive of polymicrogyria ( fig. 3 E, F).
 Cytogenetic and Microarray Results 
 Routine cytogenetic analysis of patients 1 and 2 re-
vealed a normal karyotype. DNA of the patients was hy-
bridized to Affymetrix 250K SNP arrays according to the 
Affymetrix standard protocol for the GeneChip Mapping 
250K  Nsp I arrays. Copy number analysis using the Copy 
Number    Analyzer    for   GeneChip   (CNAG)   v   3.0   [Nan-
nya et al., 2005] indicated in patient 1 a 4.1-Mb deletion 
(arr 21q22.13–q22.2 (37053718–41102161 [hg18])  ! 1, see 
 fig. 4 ). In patient 2, a 4.2-Mb deletion (arr 21q22.12q22.2 
(35337577–39585051 [hg18])  ! 1) was observed, ( fig. 4 ). In 
both cases parental DNA analysis by quantitative PCR 
showed a de novo origin of the deletion. The deletions 
were confirmed by fluorescent in situ hybridization 
(FISH) with chromosome 21 BAC clones (RP11–166F15 
absent, RP1–63H24 present). Analysis of the B allele ratio 
of the Affymetrix array in Nexus Copy Number software 
(Biodiscovery) revealed the possibility that in patient 1 
the deletion was present in mosaic form in leukocyte 
DNA. Additional FISH analysis confirmed the mosaic in 
cultured lymphocytes where 50% of the nuclei  showed 
the presence of 2 normal copies of chromosome 21. In 
order to define the deletion breakpoint in patient 2 more 
precisely, qPCR experiments were performed on patient 
DNA (primer sequences available on request). This re-
sulted in refinement of the borders, defining the deletion 
from basepair 35346296 to 39576472 (NCBI built 36.3), 
and, using extra- and intragenic probes,  RUNX1 was ex-
cluded from the proximal end of the deletion.
A B C
A B
DC
 Fig. 1. Facial features of patient 1.  A Age unknown. Note the full upper eyelids and cheeks, anteverted nares, 
down-turned corners of the mouth and large ears.  B ,  C Age 7 years. Note thick eyebrows, full upper eyelids and 
cheeks, slightly anteverted nares, down-turned corners of the mouth, dental decay and large, low-set ears. 
 Fig. 2. Facial features of patient 2.  A Age 8 months. Note the full 
upper eyelids and cheeks, anteverted nares and down-turned cor-
ners of the mouth.  B Severe dental decay and malshaped teeth.
 C ,  D Age 7 years. Note thick eyebrows, Peters anomaly of the right 
eye, full upper eyelids and cheeks, anteverted nares and down-
turned corners of the mouth, malformed ears and moody expres-
sion. 
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 The deletion areas of the 2 patients partially overlap 
from base pair 37053718 to 39585051 spanning 2.5 Mb on 
chromosome 21q22.13–q22.2, encompassing 27 genes (15 
protein coding genes, 3 non-protein coding genes, 4 pseu-
dogenes and 5 hypothetical genes) according to the NCBI 
and Ensembl database annotation build 36.3 ( table  2 ). 
The  DYRK1A gene, previously associated with neurode-
velopmental anomalies and microcephaly [Møller et al., 
2008], is included in the shared deletion area.
 Review of 21q22 Deletions Including  DYRK1A 
 Several features have been repeatedly described in 
partial monosomy 21 including intrauterine and postna-
tal growth retardation, down-slanting palpebral fissures, 
low-set ears, arthrogryposis-like signs, hypertonia, heart 
defect, and mental retardation [Chettouh et al., 1995]. In 
order to delineate a more specific phenotype relating to 
21q22 deletions we searched PubMed, Decipher and En-
sembl databases for patients with these deletions. Most of 
the patients reported in the literature have microscopic 
deletions with poorly defined breakpoints. We review 
only those where we can deduce overlap with the 
21q22.13–q22.2 critical region of our patients and where 
the phenotypic description is sufficient for comparison. 
These are summarized in  table 1 . The findings are fairly 
consistent regarding intra-uterine growth retardation 
(IUGR), microcephaly, mental retardation, seizures, cor-
pus callosum abnormalities and facial features (deep-set 
eyes, micrognathia, and dysplastic ears).
 Of note, also one patient described by Shinawi et al. 
[2008] and one by Yao et al. [2006] show the deletion in 
mosaic form.
 Discussion 
 The 2 patients presented in this study show a distinc-
tive phenotype that to our knowledge has not previously 
been recognized in patients with 21q22 deletions. They 
exhibit severe mental retardation with absence of speech, 
microcephaly, short stature, and distinct cerebral abnor-
malities. Their facial features with square forehead, full 
eyebrows and eyelids, deep-set eyes, broad nasal ridge, 
and down-turned corners of the mouth are strikingly 
alike and give them a ‘moody’ appearance. Brain MRI 
findings are quite similar in the patients, showing under-
development of frontal lobes with evidence of a migration 
disorder in patient 2, deep frontotemporal sulci, large lat-
eral and third ventricles, loss of periventricular white 
matter, callosal dysgenesis and thin brain stem. The low 
resolution MRI of patient 1 did not allow recognition of 
minor cortical malformations.
 Because of their resembling features, it is likely that 
genes in their common deleted area are causative of their 
phenotype.  DYRK1A [OMIM 600855] maps to chromo-
some 21q22.13 and is included in the deleted area of both 
patients. With its location within the Down syndrome 
A B
C D
E F
 Fig. 3. Brain T1 weighed MRI images.  A– D Note cerebral atrophy/
underdevelopment of frontal and temporal lobes, widened ven-
tricles including the 3rd ventricle, thin corpus callosum and brain 
stem.  A Patient 1, midsaggital section.  B Patient 1, transversal sec-
tion.  C Patient 2, midsagittal section.  D Patient 2, transversal sec-
tion.  E ,  F Patient 2, note periventricular nodular heterotopia and 
area suspected of polymicrogyria in the right frontal lobe ( E ). Cor-
onal section ( F ). Magnification of  E , upper arrow points to hetero-
topia, lower arrow points to the area suspected of polymicrogyria. 
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Table 2.  Known genes in overlapping deletion area
Gene symbol Name OMIM
HLCS Holocarboxylase synthethase 609018
DSCR6 Down syndrome critical region gene 6 609892
PIGP Phosphatidylinositol glycan anchor biosynthesis, class P 605938
TTC3 Tetratricopeptide repeat domain 3 602259
DSCR9 Down syndrome critical region gene 9 –
DSCR3 Down syndrome critical region gene 3 605298
DYRK1A Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A 600855
KCNJ6 Potassium channel, inwardly rectifying, subfamily J, member 6 600877
DSCR4 Down syndrome critical region gene 4 604829
DSCR8 Down syndrome critical region gene 8 –
DSCR10 Down syndrome critical region gene 10 –
KCNJ15 Potassium channel, inwardly rectifying, subfamily J, member 15 602106
ERG V-ets erythroblastosis virus E26 onco gene homolog 165080
C21orf24 Chromosome 21 open reading frame 24 611723
ETS2 V-ets erythroblastosis virus E26 onco gene homolog 2 164740
AP001042.1 FLJ45139 protein –
PSMG1 Proteasome assembly chaperone 1 (DSCR2) 605296
BRWD1 Bromodomain and WD repeat domain 1 –
 Fig. 4. Array results. Under the schematic 
representation of chromosome 21 the ac-
tual results in the 21q22.11–q22.3 region of 
the two 250K SNP arrays are shown. In the 
bottom panel the overlapping segments 
and several genes in the area are depicted. 
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critical region,  DYRK1A has been suggested to play a cru-
cial role in brain alterations both in trisomy and mono-
somy 21 patients [Song et al., 1996]. Møller et al. [2008] 
reported 2 patients with a translocation truncating the 
 DYRK1A gene. Both patients exhibited prenatal onset mi-
crocephaly, intrauterine growth retardation, feeding 
problems, developmental delay and seizures. In the first 
patient retardation was mild, and he had large, low-set 
ears, long philtrum, and micrognathia. On brain MRI 
hypogenesis of the corpus callosum was described with-
out other abnormalities. The second patient had severe 
mental retardation, absent speech, large ears, flat phil-
trum and a ventricular septum defect. Brain MRI showed 
enlarged ventricles. The  DYRK1A gene is the human ho-
molog of the Drosophila  minibrain gene [Tejedor et al., 
1995]. It is highly conserved in mammals. In mice,  Dyr-
k1a haploinsuffiency leads to a reduced body size with a 
disproportionate brain reduction, and developmental de-
lay [Fotaki et al., 2002]. In particular, underdevelopment 
of the ventral mid- and hindbrain structures was present 
in  Dyrk1A +/– mice. The MRI findings of our patients with 
large third ventricle, thin corpus callosum and brain 
stem might relate to the  DYRK1A haploinsufficiency.
 Besides  DYRK1A , there are 14 protein coding and 3 
non-protein coding genes annotated in the common de-
leted area, each of which might contribute to the pheno-
type. Six of these are Down-syndrome critical region 
(DSCR) genes of unknown function. Among the genes 
with known function,  TTC3 ,  KCNJ6 and  BRDW1 are also 
interesting candidates.
 The TTC3 (tetratricopeptide repeat domain 3) gene is 
involved in neuronal cell differentiation and particularly 
in regulation of neurite extension [Berto et al., 2007], sug-
gesting that absence of  TTC3 could be related to in cogni-
tive problems and brain underdevelopment. The tetratri-
copeptide domain is also present in kinesins responsible 
for the organization of axonal microtubules and cytoskel-
eton dynamics and in  KIAA1279 , the gene mutated in 
Goldberg-Shprintzen syndrome [Brooks et al., 2005].
 KCNJ6 [OMIM 600877], also known as  GIRK2 , is 
 expressed in the brain and the pancreatic   -cell. Homo-
zygous  Girk2 missense mutation in  weaver mice causes 
severe cerebellar ataxia and altered behavioral pattern 
[Patil et al., 1995; Pravetoni and Wickman, 2008]. Hetero-
zygous  weaver mice have a decreased number of surviv-
ing granule cells and suffer sporadically from tonic-clon-
ic seizures [Patil et al., 1995]. Also, homozygous weaver 
 mice have decreased levels of circulating IGF1 and re-
sponded to GH-treatment [Yao et al., 2007]. The postna-
tal growth retardation in our patients might be partially 
explained by a deficient GH/IGF1 axis, as seen in mutant 
 weaver mice.
 Mutations in the  RUNX1 gene [OMIM 151385] cause 
familial platelet disorder with propensity to acute my-
eloid leukemia [FPD/AML; OMIM 601399]. Shinawi et al. 
[2008] reviewed platelet pool storage disease caused by 
 RUNX1 haploinsufficiency and described multiple prob-
lems of microdeletions at 21q22 ascribed to  RUNX1 and 
 DYRK1A . Surprisingly, both our patients were diagnosed 
with low platelet counts, although  RUNX1 is not deleted. 
Possibly, regulatory elements of  RUNX1 are affected by 
the deletion or other genes in the critical area are involved 
in platelet disorders. In mice, regulatory elements have 
been identified distant (300 kb) from  Runx1 [Soler et al., 
2010].
 Periventricular nodular heterotopia (PNH) are a new 
finding in 21q22 deletion. PNH is considered a malfor-
mation of cortical development. Of note, other cortical 
malformations, that is polymicrogyria [Yao et al., 2006; 
Beri-Dexheimer et al., 2008; Dobyns et al., 2008] and lis-
sencephaly [Miller et al., 2009], have been associated with 
21q deletions. Yao et al. [2006] propose that an 8.4-Mb 
region on 21q22.11–q22.3 is associated with cortical dys-
plasia. However, the large size of this area and lack of 
breakpoint details make the comparison of these patients 
with ours incomplete.
 Our findings suggest that a minimum 2.5-Mb mi-
crodeletion at chromosome 21q22.13–q22.2 including 
 DYRK1A and excluding  RUNX1 is responsible for a char-
acteristic syndrome with recognizable facial features, se-
vere developmental delay, brain abnormalities, IUGR, 
and eye and platelet abnormalities. Our observation re-
duces the chromosomal area to which these abnormali-
ties have been previously ascribed, and should encourage 
high resolution array analysis in patients with a similar 
phenotype. It could be worthwhile searching for muta-
tions in  DYRK1A in patients with a similar phenotype in 
whom microdeletions have been excluded.
 Acknowledgements 
 We would like to thank the patients and their families for their 
cooperation with this study and R. Koppenol for kindly providing 
the figures. 
 Oegema et al. Mol Syndromol 2010;1:113–120120
 References 
 Bartsch O, Hinkel GK, Petersen MB, Konig U, 
Bugge M, et al: A large family with subtelo-
meric translocation t(18; 21)(q23;q22.1) and 
molecular breakpoint in the Down syn-
drome critical region. Hum Genet 100: 669–
675 (1997). 
 Beri-Dexheimer M, Latger-Cannard V, Philippe 
C, Bonnet C, Chambon P, et al: Clinical 
 phenotype of germline RUNX1 haploinsuf-
ficiency: from point mutations to large ge-
nomic deletions. Eur J Hum Genet 16: 1014–
1018 (2008). 
 Berto G, Camera P, Fusco C, Imarisio S, Ambro-
gio C, et al: The Down syndrome critical re-
gion protein TTC3 inhibits neuronal differ-
entiation via RhoA and Citron kinase. J Cell 
Sci 120: 1859–1867 (2007). 
 Brooks AS, Bertoli-Avella AM, Burzynski GM, 
Breedveld GJ, Osinga J, et al: Homozygous 
nonsense mutations in KIAA1279 are asso-
ciated with malformations of the central and 
enteric nervous systems. Am J Hum Genet 
77: 120–126 (2005). 
 Chettouh Z, Croquette MF, Delobel B, Gilgen-
krants S, Leonard C, et al: Molecular map-
ping of 21 features associated with partial 
monosomy 21: involvement of the APP-
SOD1 region. Am J Hum Genet 57: 62–71 
(1995). 
 Decipher: https://decipher.sanger.ac.uk/applica-
tion/ 
 Dobyns WB, Mirzaa G, Christian SL, Petras K, 
Roseberry J, et al: Consistent chromosome 
abnormalities identify novel polymicrogyria 
loci in 1p36.3, 2p16.1–p23.1, 4q21.21–q22.1, 
6q26–q27, and 21q2. Am J Med Genet A 
 146A:1637–1654 (2008). 
 Ehling D, Kennerknecht I, Junge A, Prager B, Ex-
eler R, et al: Mild phenotype in two unrelated 
patients with a partial deletion of 21q22.2–
q22.3 defined by FISH and molecular stud-
ies. Am J Med Genet A 131: 265–272 (2004). 
 Ensembl: http://www.ensembl.org/ 
 Fotaki V, Dierssen M, Alcantara S, Martinez S, 
Marti E, et al:  Dyrk1A haploinsufficiency af-
fects viability and causes developmental de-
lay and abnormal brain morphology in mice. 
Mol Cell Biol 22: 6636–6647 (2002). 
 Fryns JP, D’Hondt F, Goddeeris P, van den Ber-
ghe H: Full monosomy 21: a clinically recog-
nizable syndrome? Hum Genet 37: 155–159 
(1977). 
 Fujita H, Torii C, Kosaki R, Yamaguchi S, Kudoh 
J, et al: Microdeletion of the Down syndrome 
critical region at 21q22. Am J Med Genet A 
 152A:950–953 (2010). 
 Holbek S, Friedrich U, Brostrom K, Petersen GB: 
Monosomy for the centromeric and juxta-
centromeric region of chromosome 21. 
Humangenetik  24: 191–195 (1974). 
 Huret JL, Leonard C, Chery M, Philippe C, Scha-
fei-Benaissa E, et al: Monosomy 21q: two cas-
es of del(21q) and review of the literature. 
Clin Genet  48: 140–147 (1995). 
 Joosten AM, De Vos S, Van Opstal D, Branden-
burg H, Gaillard JL, et al: Full monosomy 21, 
prenatally diagnosed by fluorescent in situ 
hybridization. Prenat Diagn 17:  271–275 
(1997). 
 Korenberg JR, Kalousek DK, Anneren G, Pulst 
SM, Hall JG, et al: Deletion of chromosome 
21 and normal intelligence: molecular defi-
nition of the lesion. Hum Genet 87: 112–118 
(1991). 
 Krasikov N, Takaesu N, Hassold T, Knops JF, 
Finley WH, et al: Molecular and cytogenetic 
investigation of complex tissue-specific du-
plication and loss of chromosome 21 in a 
child with a monosomy 21 phenotype. Am J 
Med Genet 43: 554–560 (1992). 
 Lindstrand A, Malmgren H, Sahlen S, Schou-
mans J, Nordgren A, et al: Detailed molecu-
lar and clinical characterization of three pa-
tients with 21q deletions. Clin Genet 77: 
 145–154 (2010). 
 Lyle R, Bena F, Gagos S, Gehrig C, Lopez G, et al: 
Genotype-phenotype correlations in Down 
syndrome identified by array CGH in 30 cas-
es of partial trisomy and partial monosomy 
chromosome 21. Eur J Hum Genet 17: 454–
466 (2009). 
 Matsui I, Yamamoto Y, Kuroki Y: Down’s syn-
drome and its countertype (21q-). Nippon 
Rinsho Suppl:1452–1453 (1978). 
 Matsumoto N, Ohashi H, Tsukahara M, Kim 
KC, Soeda E, et al: Possible narrowed assign-
ment of the loci of monosomy 21-associated 
microcephaly and intrauterine growth retar-
dation to a 1.2-Mb segment at 21q22.2. Am J 
Hum Genet 60: 997–999 (1997). 
 Miller AC, Rashid RM, Muraskas JK: A novel 
presentation of a rare chromosome 21q22.2 
deletion. Clin Dysmorphol 18: 57–58 (2009). 
 Møller RS, Kubart S, Hoeltzenbein M, Heye B, 
Vogel I, et al: Truncation of the Down syn-
drome candidate gene  DYRK1A in two unre-
lated patients with microcephaly. Am J Hum 
Genet 82: 1165–1170 (2008). 
 Mori MA, Lapunzina P, Delicado A, Nunez G, 
Rodriguez JI, et al: A prenatally diagnosed 
patient with full monosomy 21: ultrasound, 
cytogenetic, clinical, molecular, and necrop-
sy findings. Am J Med Genet A 127A:69–73 
(2004). 
 Nannya Y, Sanada M, Nakazaki K, Hosoya N, 
Wang L, et al: A robust algorithm for copy 
number detection using high-density oligo-
nucleotide single nucleotide polymorphism 
genotyping arrays. Cancer Res 65:  6071–
6079 (2005). 
 Patil N, Cox DR, Bhat D, Faham M, Myers RM, 
et al: A potassium channel mutation in weav-
er mice implicates membrane excitability in 
granule cell differentiation. Nat Genet 11: 
 126–129 (1995). 
 Pellissier MC, Philip N, Voelckel-Baeteman MA, 
Mattei MG, Mattei JF: Monosomy 21: a new 
case confirmed by in situ hybridization. 
Hum Genet  75: 95–96 (1987). 
 Pravetoni M, Wickman K: Behavioral charac-
terization of mice lacking GIRK/Kir3 chan-
nel subunits. Genes Brain Behav 7: 523–531 
(2008). 
 PubMed: http://www.ncbi.nlm.nih.gov/ 
 Shinawi M, Erez A, Shardy DL, Lee B, Naeem R, 
et al: Syndromic thrombocytopenia and 
 predisposition to acute myelogenous leuke-
mia caused by constitutional microdeletions 
on chromosome 21q. Blood 112: 1042–1047 
(2008). 
 Soler E, Andrieu-Soler CS, De Boer E, Bryne JC, 
Thongjuea S, et al: The genome-wide dy-
namics of the binding of Ldb1 complexes 
during erythroid differentiation. Genes Dev 
24: 277–289 (2010). 
 Song WJ, Sternberg LR, Kasten-Sportes C, Keur-
en ML, Chung SH, et al: Isolation of human 
and murine homologues of the  Drosophila 
minibrain gene: human homologue maps to 
21q22.2 in the Down syndrome ‘critical re-
gion’. Genomics 38: 331–339 (1996). 
 Tejedor F, Zhu XR, Kaltenbach E, Ackermann A, 
Baumann A, et al: minibrain: a new protein 
kinase family involved in postembryonic 
neurogenesis in  Drosophila . Neuron 14: 287–
301 (1995). 
 Theodoropoulos DS, Cowan JM, Elias ER, Cole 
C: Physical findings in 21q22 deletion sug-
gest critical region for 21q– phenotype in 
q22. Am J Med Genet 59: 161–163 (1995). 
 Tuschl K, Fritz B, Herle M, Fonatsch C, Bodam-
er OA: Trisomy 1q42.3–qter and monosomy 
21q22.3-qter associated with ear anomaly, 
facial dysmorphology, psychomotor retarda-
tion, and epilepsy: delineation of a new syn-
drome. Am J Med Genet A 143A:2065–2069 
(2007). 
 Yamamoto Y, Ogasawara N, Gotoh A, Komiya 
H, Nakai H, et al: A case of 21q–syndrome 
with normal SOD-1 activity. Hum Genet 48: 
 321–327 (1979). 
 Yao G, Chen XN, Flores-Sarnat L, Barlow GM, 
Palka G, et al: Deletion of chromosome 21 
disturbs human brain morphogenesis. Gen-
et Med 8: 1–7 (2006). 
 Yao W, Bethin K, Yang X, Zhong J, Lee WH: Role 
of the GH/IGF-I axis in the growth retarda-
tion of weaver mice. Endocrine 32: 227–234 
(2007). 
